TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
-15.06%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$400M
AUM Growth
+$400M
(-24%)
Cap. Flow
-$33.6M
Cap. Flow
% of AUM
-8.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Fulcrum Therapeutics
FULC
|
$17.7M |
| 2 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$15.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $139M | 34.79% |
5,524,031
| – | – |
|
2
Pliant Therapeutics
PLRX
$101M
| $78.8M | 19.73% |
5,839,160
| – | – |
|
3
Nurix Therapeutics
NRIX
$714M
| $70.1M | 17.55% |
2,422,549
| – | – |
|
|
4
Fulcrum Therapeutics
FULC
$351M
| $70.1M | 17.54% |
3,962,202
-1,000,000
| -20% | -$17.7M |
|
5
Voyager Therapeutics
VYGR
$186M
| $17.3M | 4.33% |
6,391,176
| – | – |
|
|
DBTX
6
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $14.6M | 3.65% |
3,139,685
| – | – |
|
|
JNCE
7
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $9.59M | 2.4% |
1,148,780
-1,900,000
| -62% | -$15.9M |
|